Clinical Trial Update: Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

View source ↗

Summary

Development and validation of the FBIndex, a tool to assess falls risk in patients with various neuromuscular disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Facioscapulohumeral Muscular Dystrophy
• Inclusion Body Myositis
• Lambert-eaton Myasthenic Syndrome
• Limb Girdle Muscular Dystrophy
• Myasthenia Gravis
• Myotonic Dystrophy
• Pompe Disease

Snippet

Sponsor: LMU Klinikum | Conditions: Inclusion Body Myositis, Myotonic Dystrophy | Status: ENROLLING_BY_INVITATION